These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 29868967)

  • 1. Peptide Amphiphile Micelles for Vaccine Delivery.
    Barrett JC; Tirrell MV
    Methods Mol Biol; 2018; 1798():277-292. PubMed ID: 29868967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine Adjuvant Incorporation Strategy Dictates Peptide Amphiphile Micelle Immunostimulatory Capacity.
    Zhang R; Kramer JS; Smith JD; Allen BN; Leeper CN; Li X; Morton LD; Gallazzi F; Ulery BD
    AAPS J; 2018 Jun; 20(4):73. PubMed ID: 29858738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses.
    Tsoras AN; Wong KM; Paravastu AK; Champion JA
    Front Immunol; 2020; 11():1547. PubMed ID: 32849524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide amphiphile micelles self-adjuvant group A streptococcal vaccination.
    Trent A; Ulery BD; Black MJ; Barrett JC; Liang S; Kostenko Y; David NA; Tirrell MV
    AAPS J; 2015 Mar; 17(2):380-8. PubMed ID: 25527256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modular Peptide Amphiphile Micelles Improving an Antibody-Mediated Immune Response to Group A Streptococcus.
    Barrett JC; Ulery BD; Trent A; Liang S; David NA; Tirrell MV
    ACS Biomater Sci Eng; 2017; 3(2):144-152. PubMed ID: 29242824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing cellular immunogenicity to peptide-based vaccine candidates using a fluorocarbon antigen delivery system.
    Francis JN; Thaburet JF; Bonnet D; Sizer PJ; Brown CB; Georges B
    Vaccine; 2015 Feb; 33(8):1071-6. PubMed ID: 25573036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a self-assembling and self-adjuvant lipopeptide as a saccharide-free peptide vaccine targeting EGFRvIII positive cutaneous melanoma.
    Chen Y; Yuan F; Jiang X; Lv Q; Luo N; Gong C; Wang C; Yang L; He G
    Biomater Sci; 2018 May; 6(5):1120-1128. PubMed ID: 29528348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferritin nanocage-based antigen delivery nanoplatforms: epitope engineering for peptide vaccine design.
    Wang Z; Xu L; Yu H; Lv P; Lei Z; Zeng Y; Liu G; Cheng T
    Biomater Sci; 2019 Apr; 7(5):1794-1800. PubMed ID: 30888360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines.
    Wang J; Hu X; Xiang D
    Drug Deliv; 2018 Nov; 25(1):1319-1327. PubMed ID: 29869539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo.
    Black M; Trent A; Kostenko Y; Lee JS; Olive C; Tirrell M
    Adv Mater; 2012 Jul; 24(28):3845-9. PubMed ID: 22550019
    [No Abstract]   [Full Text] [Related]  

  • 11. Method for the synthesis of highly pure vaccines using the lipid core peptide system.
    Moyle PM; Olive C; Good MF; Toth I
    J Pept Sci; 2006 Dec; 12(12):800-7. PubMed ID: 17131293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extending antigen release from particulate vaccines results in enhanced antitumor immune response.
    Kapadia CH; Tian S; Perry JL; Sailer D; Christopher Luft J; DeSimone JM
    J Control Release; 2018 Jan; 269():393-404. PubMed ID: 29146244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide Amphiphile Micelle Vaccine Size and Charge Influence the Host Antibody Response.
    Zhang R; Smith JD; Allen BN; Kramer JS; Schauflinger M; Ulery BD
    ACS Biomater Sci Eng; 2018 Jul; 4(7):2463-2472. PubMed ID: 33435110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linker chemistry determines secondary structure of p5314-29 in peptide amphiphile micelles.
    Missirlis D; Farine M; Kastantin M; Ananthanarayanan B; Neumann T; Tirrell M
    Bioconjug Chem; 2010 Mar; 21(3):465-75. PubMed ID: 20166676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Filamentous phage as an immunogenic carrier to elicit focused antibody responses against a synthetic peptide.
    van Houten NE; Zwick MB; Menendez A; Scott JK
    Vaccine; 2006 May; 24(19):4188-200. PubMed ID: 16488517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.
    Tsoras AN; Champion JA
    Bioconjug Chem; 2018 Mar; 29(3):776-785. PubMed ID: 29436221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune peptide enhancement of peptide based vaccines.
    Rosenthal KS
    Front Biosci; 2005 Jan; 10():478-82. PubMed ID: 15574384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles.
    Sabhnani L; Manocha M; Sridevi K; Shashikiran D; Rayanade R; Rao DN
    FEMS Immunol Med Microbiol; 2003 Oct; 38(3):215-29. PubMed ID: 14522457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.